Saudi Arabia Stem Cells Market Size & Outlook, 2025-2030
The stem cells market in Saudi Arabia is expected to reach a projected revenue of US$ 189.0 million by 2030. A compound annual growth rate of 11.1% is expected of Saudi Arabia stem cells market from 2025 to 2030.
The Saudi Arabia stem cells market generated a revenue of USD 100.3 million in 2024 and is expected to reach USD 189.0 million by 2030.
The Saudi Arabia market is expected to grow at a CAGR of 11.1% from 2025 to 2030.
In terms of segment, adult stem cells was the largest revenue generating product in 2024.
Induced Pluripotent Stem Cells is the most lucrative product segment registering the fastest growth during the forecast period.
Stem cells market data book summary
Market revenue in 2024
USD 100.3 million
Market revenue in 2030
USD 189.0 million
Growth rate
11.1% (CAGR from 2024 to 2030)
Largest segment
Adult stem cells
Fastest growing segment
Induced Pluripotent Stem Cells
Historical data
2018 - 2023
Base year
2024
Forecast period
2025 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells
Key market players worldwide
Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp
Other key industry trends
In terms of revenue, Saudi Arabia accounted for 0.6% of the global stem cells market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Middle East & Africa, South Africa stem cells market is projected to lead the regional market in terms of revenue in 2030.
UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 138.0 million by 2030.
Saudi Arabia has become the first Arabian country with more than 10,000 stem cell donors. This indicates the increasing adoption of stem cell therapies in the country. Such initiatives are expected to drive the market for mesenchymal stem cells in Saudi Arabia.
In addition, major companies such as Celltex Therapeutics Corporation are expanding their business in Saudi Arabia. In March 2019, Celltex Therapeutics Corporation signed a Memorandum of Understanding with the Research Products Development Company (RPDC) for the commercialization of the company’s stem cell technology.
Such companies are anticipated to propel the market in the country. Furthermore, King Abdulaziz University is one of the major contributors to stem cell research in the country. For instance, in February 2018, the university undertook an initiative to evaluate in vitro chondrocyte differentiation.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Stem Cells Market Outlook will help companies and investors design strategic landscapes.
Adult Stem Cells was the largest segment with a revenue share of 83.85% in 2024.
Horizon Databook has segmented the Saudi Arabia stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Saudi Arabia has become the first Arabian country with more than 10,000 stem cell donors. This indicates the increasing adoption of stem cell therapies in the country. Such initiatives are expected to drive the market for mesenchymal stem cells in Saudi Arabia.
In addition, major companies such as Celltex Therapeutics Corporation are expanding their business in Saudi Arabia. In March 2019, Celltex Therapeutics Corporation signed a Memorandum of Understanding with the Research Products Development Company (RPDC) for the commercialization of the company’s stem cell technology.
Such companies are anticipated to propel the market in the country. Furthermore, King Abdulaziz University is one of the major contributors to stem cell research in the country. For instance, in February 2018, the university undertook an initiative to evaluate in vitro chondrocyte differentiation.
Saudi Arabia Stem Cells Market Technology Outlook (Revenue, USD Million , 2018-2030)
Expansion and Sub-Culture
Cell Acquisition
Cell Production
Cryopreservation
Saudi Arabia Stem Cells Market Therapy Outlook (Revenue, USD Million , 2018-2030)
Allogenic
Autologous
Saudi Arabia Stem Cells Market End Use Outlook (Revenue, USD Million , 2018-2030)
Pharmaceutical and Biotechnology Companies
Hospitals & Cell Banks
Academic & Research Institutes
Saudi Arabia Stem Cells Market Product Outlook (Revenue, USD Million , 2018-2030)
Adult Stem Cells
Human Embryonic Stem Cells
Very Small Embryonic Like Stem Cells
Induced Pluripotent Stem Cells
Saudi Arabia Stem Cells Market Application Outlook (Revenue, USD Million , 2018-2030)
Regenerative Medicine
Drug Discovery and Development
Reasons to subscribe to Stem Cells Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Stem Cells Market Outlook databook
Our clientele includes a mix of Stem Cells Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia Stem Cells Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia Stem Cells Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.